ArticleJournal of clinical and translational hepatology2023

Development and Validation of a Clinical Risk Score to Predict Immune-mediated Liver Injury Caused by Sintilimab: Assessed for Causality Using Updated RUCAM.

Caiyun Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.